Generate a tailored SOP for Dr. Charles Gersbach. Improve your application with a focused, well-structured draft.
Charles Gersbach is the John W. Strohbehn Distinguished Professor of Biomedical Engineering at Duke University. He specializes in gene regulation and engineering of epigenetic systems, with a focus on developing innovative techniques to treat disease. His research encompasses a diverse range of topics including chromatin regulation, gene therapy, and CRISPR technology. Gersbach's work is recognized for its contributions to understanding neurodevelopmental disorders, immune therapies, and various genetic conditions. He has authored numerous publications in leading journals and has strengths in molecular genetics and microbial systems. At Duke, he has been actively involved in undergraduate education and research, serving as a team leader for the Duke Undergraduate International Genetically Engineered Machine (iGEM) team. Gersbach is also associated with multiple research institutes at Duke, reflecting his commitment to interdisciplinary collaboration and advancement in biomedical engineering.
Duke University • Durham, NC
Leading research and education in Biomedical Engineering.
Duke University • Durham, NC
Conducting advanced research in genetic engineering and cell therapy.
Department of Biomedical Engineering (MS program)